| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-08 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.17 | 4e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-07 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |